课题基金 / 基金详情

The Turnover Rate of Human CD4+CD25+ T cells in vivo

The Turnover Rate of Human CD4+CD25+ T cells in vivo
人CD4 CD25 T细胞体内周转率
批准号:
BB/D015251/1
负责人:
Arne Akbar
金额:
$72.94万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2006
资助国家:
英国
项目状态:
已结题
起止时间:
2006 至 --

项目摘要

项目成果

Arne Akbar的其他基金

相似基金

相关文献

中文摘要
翻译
我们的身体在受到感染生物的攻击时会产生免疫反应。这一反应的中心参与者是我们的白细胞,即对抗感染性病原体的士兵。然而,这些白细胞受到严格的命令,不能用友军的炮火攻击无助的组织,这些命令部分来自一种被称为调节细胞的特殊类型的白细胞。关于这些调节细胞是如何在体内培养的,以及它们是从哪里招募来的,人们知之甚少。该项目的主要目标是确定这些细胞是否从响应性免疫大军的队伍中招募,如果是,这涉及哪些额外的培训?我们还将确定,80岁以上的老年人的老化和潜在功能失调的免疫大军是否可以像年轻人一样被培养成调节细胞。这项研究的时机非常合适,因为我们将使用我们已经开发的两种不同的新型人类实验系统,这两种系统使我们能够在体内研究人类的免疫细胞和免疫反应。
英文摘要
Our bodies mount immune responses when attacked by infectious organisms. The central participants in this response are our white cells, the soldiers that combat the infective agents. However, these white cells are under strict orders not to attack helathy tissue by friendly fire and these commands come in part from a particular kind of white cell known as regulatory cells. Little is known about how these regulatory cells are trained in the body and where they are recruited from. The main objective of this project is to determine if these cells are recruited from the ranks of the responsive immune army and if so, what additional training does this involve ? We will also determine if the ageing and potentially dysfunctional immune army in elderly humans who are over 80 years old can be trained to become regulatory cells in the same way as those in young people. The timing of this study is highly opotimal as we will be using two different novel human experimental systems that we have already developed, that enable us to investigate immune cells and immune responses in humans in vivo.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1084/jem.20090896
发表时间: 2009-08-31
期刊: The Journal of experimental medicine
影响因子: --
作者: [Agius E, Lacy KE, Vukmanovic-Stejic M, Jagger AL, Papageorgiou AP, Hall S, Reed JR, Curnow SJ, Fuentes-Duculan J, Buckley CD, Salmon M, Taams LS, Krueger J, Greenwood J, Klein N, Rustin MH, Akbar AN]
通讯作者: Akbar AN
Mechanism for CD8+ T cell recognition and removal of senescent tissue cells during ageing
  • 批准号:
    BB/Y003365/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $102.14万
  • 财政年份:
    2024
  • 负责人:
    Arne Akbar
  • 依托单位:
Establishing a network to catalyse collaboration for reducing immune ageing (CARINA: CAtalyst Reducing ImmuNe Ageing)
  • 批准号:
    BB/W018225/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $39.64万
  • 财政年份:
    2022
  • 负责人:
    Arne Akbar
  • 依托单位:
How does blocking inflammation enhance human cutaneous immunity during ageing in vivo?
  • 批准号:
    MR/T030534/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $109.01万
  • 财政年份:
    2020
  • 负责人:
    Arne Akbar
  • 依托单位:
Senescent CD8+ T and NK cells contribute to immunopathogy duting cutaneous leishmaniasis
  • 批准号:
    MR/T015853/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $93.31万
  • 财政年份:
    2020
  • 负责人:
    Arne Akbar
  • 依托单位:
国内基金
海外基金
基于chirp-rate调制的混合扩频理论与方法研究